JO
EXAS

John Overdeck’s Exact Sciences EXAS Stock Holding History

John Overdeck’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,500
Closed -$1.74M – 3112
2023
Q4 		$1.74M Hold
23,500
– – ﹤0.01% 1699
2023
Q3 		$1.6M Hold
23,500
– – ﹤0.01% 1584
2023
Q2 		$2.21M Sell
23,500
-269,221
-92% -$21M 0.01% 1378
2023
Q1 		$19.8M Buy
292,721
+280,721
+2,339% +$18M 0.06% 377
2022
Q4 		$594K Sell
12,000
-166,385
-93% -$6.8M ﹤0.01% 1954
2022
Q3 		$5.8M Buy
178,385
+74,975
+73% +$3.09M 0.02% 699
2022
Q2 		$4.07M Buy
+103,410
New +$5.53M 0.01% 860
2021
Q2 		– Sell
-100,582
Closed -$13.3M – 4187
2021
Q1 		$13.3M Buy
+100,582
New +$13.8M 0.03% 588
2020
Q2 		– Sell
-47,999
Closed -$2.78M – 3101
2020
Q1 		$2.78M Buy
+47,999
New +$3.9M 0.02% 794
2019
Q4 		– Sell
-6,254
Closed -$565K – 3731
2019
Q3 		$565K Sell
6,254
-43,095
-87% -$4.91M ﹤0.01% 2464
2019
Q2 		$5.83M Sell
49,349
-315,432
-86% -$31.8M 0.02% 824
2019
Q1 		$31.6M Buy
+364,781
New +$31M 0.1% 253
2018
Q3 		– Sell
-76,727
Closed -$4.59M – 3287
2018
Q2 		$4.59M Buy
76,727
+31,909
+71% +$1.72M 0.01% 1064
2018
Q1 		$1.81M Buy
44,818
+35,452
+379% +$1.73M 0.01% 1594
2017
Q4 		$492K Buy
+9,366
New +$500K ﹤0.01% 2449
2016
Q4 		– Sell
-37,622
Closed -$699K – 3214
2016
Q3 		$699K Buy
+37,622
New +$663K ﹤0.01% 2221
2016
Q2 		– Sell
-18,238
Closed -$123K – 2986
2016
Q1 		$123K Buy
+18,238
New +$117K ﹤0.01% 2668
2014
Q2 		– Sell
-13,487
Closed -$191K – 2202
2014
Q1 		$191K Buy
13,487
+1,787
+15% +$24.1K ﹤0.01% 1822
2013
Q4 		$137K Sell
11,700
-22,291
-66% -$256K ﹤0.01% 2057
2013
Q3 		$401K Buy
33,991
+22,291
+191% +$286K ﹤0.01% 1380
2013
Q2 		$163K Buy
+11,700
New +$127K ﹤0.01% 1818

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

John Overdeck's EXAS Position: Q1 2024 in Review

John Overdeck sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 23,500 shares — an estimated $1.74M sold.

John Overdeck first reported a position in EXAS in Q2 2013 and held it in 21 quarters. The position peaked at $31.6M in Q1 2019. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • John Overdeck reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • John Overdeck sold 23,500 Exact Sciences shares in Q1 2024, an estimated $1.74M.
  • John Overdeck first reported a position in Exact Sciences in Q2 2013 and held it in 21 quarters.
  • John Overdeck's Exact Sciences position peaked at $31.6M in Q1 2019.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.